Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 1998 December;64(12) > Minerva Anestesiologica 1998 December;64(12):575-80





A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036




Minerva Anestesiologica 1998 December;64(12):575-80

language: Italian

Continuous cervical epidural anesthesia with ropivacaine in carotid surgery. Case report

Musinu C. 1, Cagetti M. 2

1 ASL n. 8 - Cagliari, Ospedale «San Giovanni di Dio», Servizio di Anestesia e Rianimazione;
2 Università degli Studi - Cagliari, Istituto di Chirurgia - Clinica Chirurgica Generale


In the light of the recent addition of ropivacai-ne as a local anesthetic to our pharmacopeia, its effects at the cervical level are examined. A patient undergoing TEAC was given continuous epidural anesthesia with ropivacaine 0.5% (total dose: 167.5 mg in three hours) at C6-C7. No supplementary i.v. anesthesic was administered intraoperatively. The results obtained were compared with those of a similar case as to type of pathology and anesthetic technique, who was anesthetised with bupivacaine 0.375% (total dose: 112.5 mg in three hours - continuous epidural anesthesia) + fentanyl (0.18 mg), supplemented intravenously with keto-prophene (200 mg) + fentanyl (0.15 mg) for analgesic reasons. From this comparison, ropivacaine 0.5% was found to have greater anesthetic potential than bupivacaine 0.375%. However, it did not appear that ropivacaine exerted a protective effect on cardiovascular conditions in the course of carotid surgery. Further anesthesiologic experiences are needed to define the validity of ropivacaine in cervical surgery.

top of page

Publication History

Cite this article as

Corresponding author e-mail